The impending epidemic of chronic cardiopulmonary disease and multimorbidity: The need for new research approaches to guide daily practice

Chest

Volumn 148, Issue 4, 2015, Pages 865-869

  Geersing, Geert Jan ^a   De Groot, Joris A ^a   Reitsma, Johannes B ^a   Hoes, Arno W ^a   Rutten, Frans H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CARDIOPULMONARY DISEASE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY ASSESSMENT; DISEASE ASSOCIATION; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; HEART FAILURE; HUMAN; LUNG DISEASE; META ANALYSIS (TOPIC); MORBIDITY; MULTIMORBIDITY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; HEALTH; HEALTH SERVICE; LUNG DISEASES; PRACTICE GUIDELINE; TRENDS;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; GLOBAL HEALTH; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LUNG DISEASES; MORBIDITY; PRACTICE GUIDELINES AS TOPIC;

EID: 84943381718     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-3172     Document Type: Note

References (24)

1. Kotecha D, Holmes J, Krum H, et al; Beta-Blockers in Heart Failure Collaborative Group. Efficacy of b blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014; 384 (9961): 2235-2243.
2. Rutten FH, Groenwold RH, Sachs AP, Grobbee DE, Hoes AW. b -Blockers and all-cause mortality in adults with episodes of acute bronchitis: an observational study. PLoS ONE. 2013; 8 (6): e67122.
3. Schouten HJ, Geersing GJ, Oudega R, van Delden JJ, Moons KG, Koek HL. Accuracy of the Wells clinical prediction rule for pulmonary embolism in older ambulatory adults. J Am Geriatr Soc. 2014; 62 (11): 2136-2141.
4. Greenhalgh T, Howick J, Maskrey N; Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ. 2014; 348 : g3725.
5. Press MJ. Instant replay-a quarterback's view of care coordination. N Engl J Med. 2014; 371 (6): 489-491.
6. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008; 29 (1): 96-103.
7. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013; 381 (9865): 496-505.
8. Yende S, D'Angelo G, Mayr F, et al; GenIMS Investigators. Elevated hemostasis markers after pneumonia increases one-year risk of allcause and cardiovascular deaths. PLoS ONE. 2011; 6 (8): e22847.
9. Khan AR, Riaz M, Bin Abdulhak AA, et al. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS ONE. 2013; 8 (1): e52929.
10. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380 (9836): 37-43.
11. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004; 1035 : 104-116.
12. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006; 8 (7): 706-711.
13. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003; 56 (3): 221-229.
14. Begg CB, Gray R. Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika. 1984; 71 (1): 11-18.
15. Biesheuvel CJ, Vergouwe Y, Steyerberg EW, Grobbee DE, Moons KGM. Polytomous logistic regression analysis could be applied more often in diagnostic research. J Clin Epidemiol. 2008; 61 (2): 125-134.
16. van de Glind EM, Rhodius-Meester HF, Reitsma JB, HooftL, van Munster BC. Reviews of individual patient data (IPD) are useful for geriatrics: an overview of available IPD reviews. J Am Geriatr Soc. 2014; 62 (6): 1133-1138.
17. Abo-Zaid G, Guo B, Deeks JJ, et al. Individual participant data meta-analyses should not ignore clustering. J Clin Epidemiol. 2013 ;66(8):865-873.
18. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD. Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS ONE. 2013; 8 (4): e60650.
19. Riley RD, Dodd SR, Craig JV, Thompson JR, Williamson PR. Metaanalysis of diagnostic test studies using individual patient data and aggregate data. Stat Med. 2008; 27 (29): 6111-6136.
20. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010; 340 : c221.
21. Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014; 383 (9912): 156-165.
22. Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA. 2015; 313 (8): 793-794.
23. van der Leeuw J, Ridker PM, van der Graaf Y, Visseren FLJ. Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects. Eur Heart J. 2014; 35 (13): 837-843.
24. Geersing GJ, ZuithoffNPA, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014 ;348:g1340.